Suppr超能文献

脾切除术或放疗及脾切除术用于治疗淋巴肉瘤中的脾功能亢进。

Splenectomy or radiation and splenectomy for hypersplenism in lymphosarcoma.

作者信息

Shukla S K, Evans J T, Mittelman A

出版信息

J Surg Oncol. 1976;8(2):99-103. doi: 10.1002/jso.2930080202.

Abstract

This is a retrospective study of 14 patients with lymphosarcoma with hypersplenism. Eight patients received radiation to the spleen followed by splenectomy for recurrence of hypersplenism. Six patients underwent primary splenectomy for hypersplenism. Radiation decreases the size of the spleen but recurrence of hypersplenism is seen in an average of 8 mo. Splenectomy in these cases improves the hematological picture. Average postsplenectomy survival is 27.6 mo. Splenectomy alone in hypersplenism also improves the hematological picture. Postsplenectomy survival in this group is 13 mo. One case of primary lymphosarcoma of the spleen is reported.

摘要

这是一项对14例伴有脾功能亢进的淋巴肉瘤患者的回顾性研究。8例患者接受了脾脏放疗,随后因脾功能亢进复发而进行了脾切除术。6例患者因脾功能亢进而接受了一期脾切除术。放疗可减小脾脏大小,但平均8个月后会出现脾功能亢进复发。在这些病例中,脾切除术可改善血液学状况。脾切除术后的平均生存期为27.6个月。单纯脾切除术治疗脾功能亢进也可改善血液学状况。该组患者脾切除术后的生存期为13个月。报告了1例原发性脾脏淋巴肉瘤病例。

相似文献

2
Spleen irradiation in secondary hypersplenism.继发性脾功能亢进中的脾脏照射
Am J Roentgenol Radium Ther Nucl Med. 1968 Nov;104(3):668-73. doi: 10.2214/ajr.104.3.668.
4
Splenectomy for hypersplenism in malignant lymphoma.恶性淋巴瘤脾功能亢进的脾切除术
Arch Surg. 1970 Aug;101(2):348-52. doi: 10.1001/archsurg.1970.01340260252037.
5
Splenectomy in patients with malignant non-Hodgkin's lymphoma.恶性非霍奇金淋巴瘤患者的脾切除术
Eur J Haematol. 2000 Mar;64(3):145-50. doi: 10.1034/j.1600-0609.2000.90079.x.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验